Evidence map›Paper›PMID 25485946›Full record

ArticlePloS one2014

Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.

Federico Simonetta, Nicolas Gestermann, Stéphane Bloquet, Christine Bourgeois

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. IL-7Rα on CD4Journal of neuroinflammation · 2024
    Article
  2. Review
  3. Article
  4. Pleiotropic Effects of IL-33 on CD4Frontiers in immunology · 2019
    Review
  5. Article
  6. Review
  7. Article
  8. IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in mice.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Federico SimonettaINSERM, U1012, Le Kremlin-Bicêtre, France; Univ Paris-SUD, UMR-S1012, Le Kremlin-Bicêtre, France; Division of Hematology, Department of Medical Specialties, Geneva University Hospitals, Geneva, Switzerland.
Nicolas GestermannINSERM, U1012, Le Kremlin-Bicêtre, France; Univ Paris-SUD, UMR-S1012, Le Kremlin-Bicêtre, France.
Stéphane BloquetAnimalerie centrale, Faculté de Médecine Paris-Sud, Univ Paris-Sud, Le Kremlin-Bicêtre, France.
Christine BourgeoisINSERM, U1012, Le Kremlin-Bicêtre, France; Univ Paris-SUD, UMR-S1012, Le Kremlin-Bicêtre, France.
Inserm · FRUniversité Paris-Sud · FRUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vast majority of Foxp3 regulatory T cells (Treg) exhibits constitutive expression of CD25 (IL-2Rα), which allows the constitution of the high affinity IL-2Rαβγ receptor, ensuring efficient IL-2 binding by Treg. Maintenance of CD25 expression at Treg surface depends on both cell intrinsic factors and environmental stimuli such as IL-2 itself. Whether other factors can participate to maintenance of CD25 expression in vivo is at present unknown. In the present work we demonstrated that IL-7, a gamma-chain cytokine exerting a crucial role in T cell development and homeostasis, is able and necessary to sustain the expression of high levels of CD25 at Treg surface. We demonstrated that, during in vitro cultures performed in the absence of IL-2, IL-7 is able to sustain CD25 expression at Treg surface through a transcriptional mechanism. By studying mice in which IL-7 signaling is either genetically impaired or increased and by employing adoptive transfer murine models, we demonstrated that IL-7 is necessary for sustained expression of CD25 at Treg surface in vivo. To ascertain the biological impact of IL-7 mediated modulation of CD25 expression, we demonstrated that IL-7 modulation of CD25 expression at Treg surface affected their ability to efficiently bind IL-2 and transduce IL-2 signaling. Finally, we demonstrated that IL-7 dependent modulation of CD25 associated with potentiated IL-2 induced expansion of Treg in vivo. Collectively, our results identify IL-7 as a necessary factor contributing to sustained CD25 expression at Treg surface in vivo thereby affecting their ability to efficiently react to IL-2.

Indexed as

AnimalsForkhead Transcription FactorsImmunophenotypingInterleukin-2Interleukin-2 Receptor alpha SubunitInterleukin-7MiceMice, TransgenicProtein BindingSignal TransductionT-Lymphocytes, RegulatoryForkhead Transcription FactorsFoxp3 protein, mouseInterleukin-2Interleukin-2 Receptor alpha SubunitInterleukin-7

Identifiers

PMID25485946
PMCPMC4259569
OpenAlexW1978106998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.